Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹2,169 Cr₹-1,021 Cr₹223 Cr₹-1,164 Cr₹2,563 Cr

What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?

The latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA is ₹2,169 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹2,169 Cr
Mar2024₹-1,021 Cr
Mar2023₹223 Cr
Mar2022₹-1,164 Cr
Mar2021₹2,563 Cr

How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹2,169 Cr
Positive
Mar2024 ₹-1,021 Cr
Negative
Mar2023 ₹223 Cr
Positive
Mar2022 ₹-1,164 Cr
Negative
Mar2021 ₹2,563 Cr -

Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹69,608.9 Cr -0.7% 2.3% -6.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,073.0 Cr -0% -3.2% -5% Stock Analytics
DIVIS LABORATORIES ₹175,657.0 Cr 4% 5.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,121.0 Cr 3.6% 7% 22% Stock Analytics
CIPLA ₹118,431.0 Cr -3.5% -1.5% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,944.0 Cr -3.2% -3.3% -10.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.7%

2.3%

-6.9%

SENSEX

-2.6%

-1.3%

7.2%


You may also like the below Video Courses